|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA
Nominal 
0.420 +0.060 (+16.667%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 23,665 | 97.291% | 11,995 | 31,297 | 82,609 | 120,501 |
| Cost of Sales | (16,718) | 743.066% | (1,983) | (25,591) | (30,306) | (45,630) |
| Gross Profit | 6,947 | -30.613% | 10,012 | 5,706 | 52,303 | 74,871 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,369) | 6.808% | (2,218) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 7,893 | 11,037 | 7,807 | |
| Profit / (Loss) before Taxation | (16,537) | -2.183% | (16,906) | 785 | (5,612) | (27,289) | |
| Taxation | 0 | -- | 0 | (124) | 0 | (949) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (1,896) | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (18,433) | 9.032% | (16,906) | 661 | (5,612) | (28,238) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 12,842 | -11.993% | 14,592 | 6,003 | 33,871 | 34,865 |
| Depreciation & Amortisation | 615 | 93.396% | 318 | 511 | 10,537 | 11,275 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | -2.240 | -26.073% | -3.030 | 0.250 | -2.500 | -14.900 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | (0.117) | -- | (0.411) | (0.131) | (1.042185) | (1.226828) |
| Remarks: | Real time quote last updated: 24/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -18,433 |
| %Change | 9.032% |
| EPS / (LPS) | RMB -0.022 |
| NBV Per Share (¥) | RMB -0.117 |